Literature DB >> 11545103

Establishment and performance of a magnetic resonance cardiac function clinic.

N G Bellenger1, J M Francis, C L Davies, A J Coats, D J Pennell.   

Abstract

Our objective was to establish a cardiovascular magnetic resonance (CMR) cardiac function clinic to provide an assessment of cardiac volume, mass, and function in patients with heart failure on the same day as their cardiology outpatient clinic appointment. Sixty-four patients attended the CMR function clinic. The reproducibility, patient acceptability, and time efficiency of the CMR clinic were assessed and compared with radionuclide ventriculography (RNV) and echocardiography (echo). Reports were available in the cardiology outpatient clinic within 2 hr of the CMR appointment time. The reproducibility of volumes, ejection fraction, and mass in this heart failure population was good and comparable with CMR studies in the normal population. CMR was more acceptable to the patients than both RNV and echo (p < 0.05). The total time for CMR was less than that of RNV (42 +/- 4 and 61 +/- 4 min, respectively; p < 0.001) but more than that of echo (echo, 23 +/- 2 min; p < 0.001). Comparison of ejection fractions revealed a correlation between CMR and RNV of 0.7, but Bland-Altman limits of agreement were wide (-10.5% to 18.9%). For CMR versus echo, the correlation was 0.6, and the limits of agreement were wider (-29.9% to 23.3%). The correlation between RNV and echo was 0.2 with wider limits of agreement (-29.8% to 24. 9%). In conclusion, CMR can provide a rapid, reproducible, and patient acceptable assessment of cardiac function in heart failure patients, whereas other methods appear to have a wider variance. The high reproducibility of CMR lends itself to the follow-up of clinical progression and the effect of treatment in patients with heart failure.

Entities:  

Mesh:

Year:  2000        PMID: 11545103     DOI: 10.3109/10976640009148669

Source DB:  PubMed          Journal:  J Cardiovasc Magn Reson        ISSN: 1097-6647            Impact factor:   5.364


  19 in total

1.  Automatic vs semi-automatic global cardiac function assessment using 64-row CT.

Authors:  J Greupner; E Zimmermann; B Hamm; M Dewey
Journal:  Br J Radiol       Date:  2011-11-01       Impact factor: 3.039

Review 2.  Novel techniques for assessment of left ventricular systolic function.

Authors:  Sonal Chandra; Hicham Skali; Ron Blankstein
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

3.  Infarct zone viability influences ventricular remodelling after late recanalisation of an occluded infarct related artery.

Authors:  N G Bellenger; Z Yousef; K Rajappan; M S Marber; D J Pennell
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

4.  Non-invasive cardiac evaluation in heart failure patients using magnetic resonance imaging: a feasibility study.

Authors:  Stephanie M Shors; William G Cotts; Biljana Pavlovic-Surjancev; Mihai Gheorghiade; James C Carr; Richard M McCarthy; Scott F Pereles; Paul J Finn
Journal:  Heart Fail Rev       Date:  2005-12       Impact factor: 4.214

5.  Right ventricular regional wall curvedness and area strain in patients with repaired tetralogy of Fallot.

Authors:  Liang Zhong; Like Gobeawan; Yi Su; Ju-Le Tan; Dhanjoo Ghista; Terrance Chua; Ru-San Tan; Ghassan Kassab
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-30       Impact factor: 4.733

6.  Contrast-enhanced adenosine-stress magnetic resonance imaging--feasibility and practicability of a protocol for detection or exclusion of ischemic heart disease in an outpatient setting.

Authors:  P Bernhardt; B Levenson; T Engels; O Strohm
Journal:  Clin Res Cardiol       Date:  2006-07-14       Impact factor: 5.460

Review 7.  The emerging role of MRI in the diagnosis and management of cardiomyopathies.

Authors:  Carlos Eduardo Rochitte; Eduardo Marinho Tassi; Afonso Akio Shiozaki
Journal:  Curr Cardiol Rep       Date:  2006-02       Impact factor: 2.931

8.  Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study.

Authors:  S K Prasad; H J Dargie; G C Smith; M M Barlow; F Grothues; B A Groenning; J G F Cleland; D J Pennell
Journal:  Heart       Date:  2005-12-09       Impact factor: 5.994

9.  Hypertrophic cardiomyopathy and ultra-endurance running - two incompatible entities?

Authors:  Mathew G Wilson; Navin Chandra; Michael Papadakis; Rory O'Hanlon; Sanjay K Prasad; Sanjay Sharma
Journal:  J Cardiovasc Magn Reson       Date:  2011-11-29       Impact factor: 5.364

10.  Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study.

Authors:  N G Bellenger; K Rajappan; S L Rahman; A Lahiri; U Raval; J Webster; G D Murray; A J S Coats; J G F Cleland; D J Pennell
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.